Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 15, Issue 1, 2004, Pages 35-40

  Tregnaghi, Miguel ^a   Ussher, José ^a   Baudagna, Ana María ^a   Calvari, Miriam ^a   Graña, Gabriela ^a  

^a Hospital Infantil Municipal de Cordoba   (Argentina)

Author keywords

Hepatitis B; Immunization programs; Infant; Vaccines

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

CHILD HEALTH; DISEASE CONTROL; HEPATITIS; VACCINATION;

ARGENTINA; ARTICLE; CITY; COMPARATIVE STUDY; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EDEMA; ERYTHEMA; FEMALE; FEVER; GEOMETRY; HEMATOMA; HEPATITIS B; HUMAN; IMMUNITY; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IMMUNOREACTIVITY; INFECTION PREVENTION; INJECTION PAIN; IRRITABILITY; MALE; NEWBORN; NORMAL HUMAN; PARENT; PATHOLOGICAL CRYING; SIDE EFFECT; SKIN INDURATION; VACCINATION; WORLD HEALTH ORGANIZATION;

ARGENTINA; SOUTH AMERICA;

EID: 1342333474     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892004000100006     Document Type: Article

References (12)

1. Expanded Progamme on Immunization. Global Advisory Group - Part I. Wkly Epidemiol Rec 1992;67:11-15.
2. World Health Organization. Global Alliance for Vaccines and Immunization (GAVI). Geneva: WHO; 2001. (Fact Sheet No. 169).
3. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40(RR-13):1-25.
4. Szmuness W, Stevens CE, Harley EJ, Zang EA, OlezKo WR, William DC, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled trial in a high-risk population in the United States. N Engl J Med 1980;303:833-841.
5. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
6. Edmunds WJ, Medley GF, Nokes DJ, Hall A, Whittle H. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci 1993;253:197-201.
7. Global Alliance for Vaccines and Immunization. A smarter way to buy. Immunization Focus, November 2000:8-9.
8. Greenberg DP, Vadheim CM, Wong VK, Marcy SM, Partridge S, Greene T, et al. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age. Pediatr Infect Dis J 1996;15:590-596.
9. Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 1989; 160:766-769.
10. Adkins JC, Wagstaff AJ. Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B. Biodrugs 1998;10:137-158.
11. Poovorawan Y, Sanpavat S, Chumdermpadetsuk A, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child 1997;77:F47-F51.
12. Gonzalez ML, Gonzalez JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine 1993;11:1033-1036.